A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2011
At a glance
- Drugs Topiramate (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 04 Oct 2011 Actual end date Mar 2006 added as reported by ClinicalTrials.gov.
- 03 Oct 2006 Status change
- 26 Nov 2005 New trial record.